+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PCI Biotech - logo

PCI Biotech is a biopharmaceutical company that produces therapies to fight against cancer through creating photochemical internalisation (PCI) technology platform. This platform is divided into 3 different segments such as: fimaCHEM, fimaVACC and fimaNAc. FimaCHEM is the company's main programme and it focuses on studying bile duct cancer. The fimaVACC studies the cytotoxic effect of therapeutic cancer vaccines. The fimaNAc is used to provide the delivery of nucleic acids: mRNA and siRNA. PCI Biotech was founded in 2000 and is based in Lysaker, Norway. They are a subsidiary of PCI Biotech Holding ASA.

Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Non-Viral / Intracellular Drug Delivery Systems Market by Type of Molecule, Type of Biologics Delivered, Type of Vehicle Used, Type of Therapeutic Area, Type of Payments and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • January 2023
  • 270 Pages
  • Global
From
Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies: Industry Trends and Global Forecasts 2021-2030 - Product Thumbnail Image

Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies: Industry Trends and Global Forecasts 2021-2030

  • Report
  • February 2021
  • 256 Pages
  • Global
From
Oligonucleotide Therapy Global Market Report 2024 - Product Thumbnail Image

Oligonucleotide Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1699 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 365 Pages
  • Global
From
Cholangiocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cholangiocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Microbiome Therapeutics: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

Microbiome Therapeutics: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • October 2022
  • 220 Pages
  • Global
From
RNA Vaccine Patent Landscape 2021 - Product Thumbnail Image

RNA Vaccine Patent Landscape 2021

  • Report
  • January 2021
  • 109 Pages
  • Global
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1561 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Cellular Tumor Antigen p53 Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Cellular Tumor Antigen p53 Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • May 2022
  • 91 Pages
  • Global
From
PCI Biotech Holding ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

PCI Biotech Holding ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
  • 14 Results (Page 1 of 1)
Loading Indicator